SCHEMBL4876626

SCHEMBL4876626

COc1cccc(C2(CNS(=O)(=O)NC(=O)O)CCC(NCc3ccc(S(C)(=O)=O)cc3)CC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MMP1 P03956 2/20 0.39
MMP2 P08253 2/20 0.39
MMP3 P08254 2/20 0.39
MMP13 P45452 2/20 0.39
CCR5 P51681 1/20 0.37
SOAT1 P35610 2/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
MAPT P10636 2/20 0.35
OPRM1 P35372 2/20 0.35
OPRL1 P41146 2/20 0.35
HPGD P15428 1/20 0.35
PKM P14618 2/20 0.35
NPY1R P25929 1/20 0.35
KCNH2 Q12809 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876621 1.00 ALDH1A1 (0.40) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4868374 0.93 ALDH1A1 (0.43) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4868389 0.93 ALDH1A1 (0.43) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4871938 0.92 MMP1 (0.42) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4878196 0.92 MMP1 (0.42) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4871944 0.92 MMP1 (0.42) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4877167 0.89 ALDH1A1 (0.45) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4877173 0.89 ALDH1A1 (0.45) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4872172 0.86 MMP1 (0.42) ALDH1A1MMP1MMP2MMP3MMP13
SCHEMBL4872167 0.86 MMP1 (0.42) ALDH1A1MMP1MMP2MMP3MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 ALDH1A1 2899/4885MMP1 3963/4885MMP2 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.